Ferozsons Laboratories Limited (PSX: FEROZ)
Pakistan
· Delayed Price · Currency is PKR
334.83
-4.55 (-1.34%)
At close: Jan 27, 2025
Ferozsons Laboratories Revenue
Ferozsons Laboratories had revenue of 4.53B PKR in the quarter ending September 30, 2024, with 2.27% growth. This brings the company's revenue in the last twelve months to 15.96B, up 19.79% year-over-year. In the fiscal year ending June 30, 2024, Ferozsons Laboratories had annual revenue of 15.85B with 38.38% growth.
Revenue (ttm)
15.96B
Revenue Growth
+19.79%
P/S Ratio
0.89
Revenue / Employee
8.42M
Employees
1,896
Market Cap
14.20B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 15.85B | 4.40B | 38.38% |
Jun 30, 2023 | 11.46B | 2.13B | 22.80% |
Jun 30, 2022 | 9.33B | 450.80M | 5.08% |
Jun 30, 2021 | 8.88B | 2.67B | 42.93% |
Jun 30, 2020 | 6.21B | 409.49M | 7.06% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 56.23B |
Abbott Laboratories (Pakistan) | 63.81B |
The Searle Company | 28.32B |
AGP Limited | 23.45B |
Highnoon Laboratories | 23.02B |
Shifa International Hospitals | 24.67B |
Citi Pharma | 12.93B |
Otsuka Pakistan | 3.18B |